This is a prospective, single-cohort, single-center, observational study to assess if learning one's Alzheimer's disease biomarker test result impacts longitudinal psychosocial, behavioral, and neuropsychological outcomes, and to identify factors that moderate and mediate these outcomes. Participants enrolled in this study are requested to complete surveys at four timepoints after learning their Alzheimer's biomarker test results.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Impact of Neuroimaging in Alzheimer's Disease (INI-AD) Score
Timeframe: 1 month, 6 months, 12 months, 18 months
Stigma Impact Scale (SIS) Score
Timeframe: 1 month, 6 months, 12 months, 18 months
Control, Autonomy, Self-Realization, and Pleasure (CASP-12)
Timeframe: baseline, 1 month, 6 months, 12 months, 18 months
Future Time Perspective Scale
Timeframe: baseline, 1 month, 6 months, 12 months, 18 months